retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial just made bariatric surgery nervous. 🔥 Eli Lilly and Company's — targeting + + — just delivered 3 data that may redefine what medical retatrutide triple hormone receptor agonist

An ongoing assessment of osteoarthritis in African Americans and Caucasians in North Carolina: The Johnston County Osteoarthritis Project

Tirzepatide/L-Carnitine belongs to a group of drugs called glucose-dependent insulinotropic polypeptide ( GIP ) and glucagon-like peptide-1 ( GLP-1 ) receptor agonists

The most common side effects reported in trials include mild to moderate gastrointestinal issues: nausea, diarrhea, vomiting, and constipation

And we can put a Band-Aid on that

The relationship between GLP-1 receptor agonists and sugar cravings is an area of growing research interest, though definitive evidence remains limited